Capping the trade margin on oxygen concentrators by the federal government has resulted in guaranteeing consumer financial savings as the worth of the essential gadget has come down, the Ministry of Chemicals and Fertilizers mentioned on Friday.
On June 3, the National Pharmaceutical Pricing Authority (NPPA) capped the trade margin on oxygen concentrators at 70 per cent on the worth to distributor (PTD) degree.
In accordance with it, “a complete of 104 producers / importers of oxygen concentrators have submitted revised MRP for 252 merchandise/manufacturers,” it mentioned.
Downward revision in worth by as much as 54 per cent has been reported in 70 manufacturers, exhibiting discount in most retail worth by as much as Rs 54,337 per unit. Further, 58 manufacturers have reported worth discount of as much as 25 per cent and 11 manufacturers reported worth discount of 26-50 per cent, the assertion mentioned.
“Out of 252 products/brands reported, 18 products/brands reported by the domestic manufacturers did not show any decline in prices,” it added.
The trade margin rationalisation for oxygen concentrators has resulted in guaranteeing consumer financial savings by eliminating unreasonable revenue margins in imported merchandise, the Ministry mentioned.
The revised MRP efficient from June 9, 2021 on all of the manufacturers and specs has been shared with the State Drug Controllers for strict monitoring and enforcement, it added.
“In order to monitor availability, the manufacturers / importers of oxygen concentrators have been directed to submit monthly stock details,” the assertion mentioned.
Oxygen concentrator is a non-scheduled drug and presently underneath the voluntary licensing framework of Central Drugs Standard Control Organisation (CDSCO).
In February 2019, NPPA had efficiently capped the trade margin on anti-cancer medicine.
(Only the headline and movie of this report could have been reworked by the Business Standard workers; the remainder of the content material is auto-generated from a syndicated feed.)